Related Experiment Video

Updated: Jun 18, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Community-associated methicillin-resistant Staphylococcus aureus in acute musculoskeletal infection in children: a

Kelly L Vander Have1, Boaz Karmazyn, Maneesh Verma

  • 1Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI 48109, USA. klvander@med.umich.edu

Journal of Pediatric Orthopedics
|November 26, 2009
PubMed
Abstract

Insights

Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) causes severe pediatric musculoskeletal infections. Aggressive surgical treatment and antibiotics are crucial but long-term complications remain a concern.

Area of Science:

  • Pediatric Infectious Diseases
  • Musculoskeletal Infections
  • Bacterial Pathogenesis

Background:

  • Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is a growing threat in pediatric musculoskeletal infections.
  • This pathogen causes invasive infections in previously healthy children.

Purpose of the Study:

  • To characterize the clinical presentation, course, treatment, and outcomes of CA-MRSA musculoskeletal infections in children.
  • To identify potential complications and long-term morbidity associated with these infections.

Main Methods:

  • Retrospective case series involving 27 pediatric patients from two institutions.
  • Data collected included clinical presentation, treatment interventions, and patient outcomes.
  • Magnetic resonance imaging (MRI) was utilized for diagnosis.

Main Results:

  • The majority of infections involved the extremities.
  • 12 patients required intensive care unit admission, with 4 experiencing acute multisystem failure.
  • Seven patients developed deep venous thrombosis and septic pulmonary emboli.
  • All patients underwent surgical intervention, with 16 requiring multiple debridements.

Conclusions:

  • CA-MRSA musculoskeletal infections pose a significant limb- and life-threatening risk to children.
  • Prompt recognition, aggressive surgical drainage/debridement, and prolonged antibiotic therapy are essential.
  • Despite aggressive management, substantial long-term morbidity is possible.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...